Verano Holdings (VRNO) Equity Average (2022 - 2026)
Verano Holdings (VRNO) reported Equity Average of $695.4 million for Q1 2026, down 26.51% year-over-year from $946.2 million in Q1 2025, and down 12.53% quarter-over-quarter from $795.0 million in Q4 2025.
Verano Holdings (VRNO) Equity Average (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 5 years of Equity Average data on file, last reported at $695.4 million in Q1 2026.
- Equity Average for Q1 2026 came in at $695.4 million, down 26.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $695.4 million (down 26.51% YoY), and the FY2025 annual result was $827.5 million, down 24.46% from the prior year.
- Equity Average eased to $695.4 million in Q1 2026 per VRNO's latest filing, from $795.0 million in the prior quarter.
- Over five years, Equity Average peaked at $1.5 billion in Q3 2022 and troughed at $695.4 million in Q1 2026.
- A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Equity Average.
- The sharpest annual moves came in 2024 and 2025: Equity Average dropped 7.43% in 2024, then retreated 26.69% in 2025.
- A 5-year view of Equity Average shows it stood at $1.4 billion in 2022, then retreated by 11.39% to $1.3 billion in 2023, then retreated by 15.07% to $1.1 billion in 2024, then dropped by 26.69% to $795.0 million in 2025, then fell by 12.53% to $695.4 million in 2026.
- Business Quant data shows VRNO's Equity Average at $695.4 million in Q1 2026, $795.0 million in Q4 2025, and $906.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 695.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 695.36 Mn |
| Dec 31, 2025 | 795.01 Mn |
| Sep 30, 2025 | 906.55 Mn |
| Jun 30, 2025 | 934.42 Mn |
| Mar 31, 2025 | 946.21 Mn |
| Dec 31, 2024 | 1.08 Bn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.23 Bn |
| Mar 31, 2024 | 1.24 Bn |
| Dec 31, 2023 | 1.28 Bn |
| Sep 30, 2023 | 1.32 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.44 Bn |
| Sep 30, 2022 | 1.54 Bn |